Wambolt & Associates, LLC Novartis Ag Transaction History

Wambolt & Associates, LLC

$291 Million
Q1 2025

A detailed history of Wambolt & Associates, LLC transactions in Novartis Ag stock. As of the latest transaction made, Wambolt & Associates, LLC holds 27,021 shares of NVS stock, worth $3.05 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

27,021

Previous 26,578 1.67%

Holding current value

$3.05 Million

Previous $2.59 Million 16.47%

% of portfolio

1.04%

Previous 0.83%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$97.14 - $115.57 $43,033 - $51,197	443 Added 1.67%	27,021 $3.01 Million
Q4 2024 Feb 11, 2025	SELL	$96.78 - $117.18 $484,964 - $587,188	-5,011 Reduced 15.86%	26,578 $2.59 Million
Q3 2024 Nov 08, 2024	BUY	$106.13 - $120.89 $148,475 - $169,125	1,399 Added 4.63%	31,589 $3.63 Million
Q2 2024 Aug 07, 2024	BUY	$92.57 - $107.37 $181,900 - $210,982	1,965 Added 6.96%	30,190 $3.21 Million
Q1 2024 Apr 30, 2024	BUY	$95.27 - $108.47 $326,299 - $371,509	3,425 Added 13.81%	28,225 $2.73 Million
Q4 2023 Feb 07, 2024	BUY	$92.27 - $101.54 $321,099 - $353,359	3,480 Added 16.32%	24,800 $2.5 Million
Q3 2023 Nov 06, 2023	BUY	$94.73 - $105.13 $179,892 - $199,641	1,899 Added 9.78%	21,320 $2.17 Million
Q2 2023 Aug 02, 2023	BUY	$92.52 - $104.91 $68,649 - $77,843	742 Added 3.97%	19,421 $1.96 Million
Q1 2023 May 05, 2023	BUY	$80.03 - $92.81 $58,341 - $67,658	729 Added 4.06%	18,679 $1.72 Million
Q4 2022 Jan 31, 2023	BUY	$75.55 - $92.52 $41,703 - $51,071	552 Added 3.17%	17,950 $1.63 Million
Q3 2022 Oct 18, 2022	BUY	$74.61 - $87.26 $13,355 - $15,619	179 Added 1.04%	17,398 $1.32 Million
Q2 2022 Aug 01, 2022	BUY	$80.52 - $93.75 $72,790 - $84,750	904 Added 5.54%	17,219 $1.46 Million
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $59,121 - $66,877	738 Added 4.74%	16,315 $1.43 Million
Q4 2021 Feb 08, 2022	BUY	$79.7 - $88.13 $134,693 - $148,939	1,690 Added 12.17%	15,577 $1.36 Million
Q3 2021 Oct 20, 2021	BUY	$81.78 - $95.14 $76,546 - $89,051	936 Added 7.23%	13,887 $1.14 Million
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $31,538 - $34,835	-370 Reduced 2.78%	12,951 $1.19 Million
Q1 2021 Apr 19, 2021	BUY	$83.5 - $98.47 $68,386 - $80,646	819 Added 6.55%	13,321 $1.15 Million
Q4 2020 Jan 19, 2021	BUY	$78.07 - $94.43 $43,719 - $52,880	560 Added 4.69%	12,502 $1.18 Million
Q3 2020 Nov 04, 2020	BUY	$82.14 - $91.0 $42,466 - $47,047	517 Added 4.53%	11,942 $1.04 Million
Q2 2020 Jul 23, 2020	BUY	$80.93 - $91.1 $63,691 - $71,695	787 Added 7.4%	11,425 $998,000
Q1 2020 May 11, 2020	BUY	$70.67 - $99.01 $35,052 - $49,108	496 Added 4.89%	10,638 $877,000
Q4 2019 Feb 10, 2020	BUY	$84.35 - $95.37 $68,407 - $77,345	811 Added 8.69%	10,142 $960,000
Q3 2019 Oct 15, 2019	SELL	$85.54 - $94.26 $14,285 - $15,741	-167 Reduced 1.76%	9,331 $811,000
Q2 2019 Jul 26, 2019	BUY	$75.4 - $92.8 $93,646 - $115,257	1,242 Added 15.04%	9,498 $867,000
Q1 2019 Apr 11, 2019	BUY	$75.32 - $86.15 $45,869 - $52,465	609 Added 7.96%	8,256 $689,000
Q4 2018 Jan 29, 2019	BUY	$73.66 - $82.02 $563,278 - $627,206	7,647 New	7,647 $656,000

Others Institutions Holding NVS

# of Institutions

1,523

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $243B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wambolt & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wambolt & Associates, LLC with notifications on news.

Account

Wambolt & Associates, LLC Novartis Ag Transaction History